Sanofi-Aventis Enters Diabetes Pact With AgaMatrix For Blood Glucose Monitors
AgaMatrix will develop a portfolio of blood glucose monitors exclusively for Sanofi-Aventis, which can now market an array of diabetes products.
AgaMatrix will develop a portfolio of blood glucose monitors exclusively for Sanofi-Aventis, which can now market an array of diabetes products.